Skip to content
Main Menu

Updated IRB Fees, Effective July 1, 2026

Categories: Article, News Archive

Effective July 1, 2026, the IRB will be increasing fees for new industry-sponsored studies. The updated fee schedule will affect new study, amendment, continuing review, and final project report applications submitted on or after that date. For all industry-sponsored studies initially submitted before July 1, 2026, we will invoice based on the previously-assigned fee schedules […]

Read More

MyChart Recruitment Clarification

Categories: Article, News Archive

The Clinical Research Support Office (CRSO) would like to share a friendly reminder and clarification about the required process for using MyChart as a recruitment tool and contacting potential research participants. Recently, there has been an increase in concerns raised to the Research Participant Advocate Office regarding how individuals are identified and contacted for studies. […]

Read More

Call for IRB Members

IRB service is a core faculty responsibility that brings peer expertise to ethical review and helps maintain reliable review timelines. As research activity at the University of Utah continues to increase, maintaining timely and high‑quality IRB review requires participation from faculty in all departments. Some departments with active research submissions have limited or no faculty […]

Read More

Announcing: IRB Office Hours

Categories: Article, News Archive

Beginning March 5, 2026, the University of Utah IRB will host office hours every Thursday from 10:00 AM – 11:00 AM MT via Zoom. Office hours are on a first-come, first-served basis, and is a space for students, faculty, and staff to ask questions about human subjects research at the University of Utah. You can review office hours information […]

Read More

Regulatory Guidance on Optional Data and Biospecimen Use

Categories: Article, News Archive

The NIH and HIPAA have guidance and regulations regarding mandatory future use of biospecimens and/or data collected in research that offers treatment/intervention to participants. NIH guidance focuses on ethical considerations, voluntariness, undue influence, and coercion of mandatory contribution of data/biospecimens for future use.   HIPAA regulation defines access to and use of PHI in “conditional” […]

Read More

Submitting Validated Surveys

Categories: Article, News Archive

To support thorough risk assessment, the IRB is now asking study teams to upload any questionnaires or surveys (including validated surveys) used in studies under the Surveys, Questionnaires, Etc. section of the Documents & Attachments page in their IRB application. This helps the IRB evaluate the nature of questions participants are asked, especially when these […]

Read More